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Contribution to diagnostics/prognostics of tuberculosis
in children. II. Indicative value of metal ions and biochemical 
parameters in serum
Newly introduced methods of assaying simultaneously 
copper and zinc and zinc alone in serum by fl ame atomic-
absorption spectrometry are simple and economical, es-
pecially in saving the consumption of serum material. 
Along with biochemical parameters, they have been suc-
cessfully applied to diagnostics/prognostics of tuberculo-
sis in children, through analyses of sera from pediatric 
patients with lung tuberculosis or suspected tuberculo-
sis, enabling the follow-up of therapeutic eﬃ  ciency. The 
prognostic strength of Cu and Cu/Zn ratio together with 
C-reactive protein, complement components C3 and C4, 
and erythrocyte sedimentation rate have been document-
ed.
Keywords: copper, zinc, Cu/Zn ratio, biochemical parame-
ters, children’s serum, lung tuberculosis
The role of oligoelements in infections with Mycobacterium tuberculosis is still a ques-
tion to be answered and therefore still att racting researchers’ interest. Iron, copper and 
zinc play an important role in the immune response to M. tuberculosis.
Articles dealing with the status of metal ions in tuberculosis (TBC) patients published 
recently are scarce. In addition to investigations dealing with adult patients (e.g., refs. 1–6), 
there are only a few papers dealing with childhood tuberculosis (7–10).
Moraes et al. (1) found lower levels of serum iron, higher copper and Cu/Zn ratio but 
similar zinc in adult TBC patients compared to healthy subjects. They concluded that se-
rum Cu and CRP/albumin ratio (CRP – C-reactive protein, an infl ammatory response pro-
tein) may serve as parameters indicating persistence or recurrence of TBC infection. Cer-
nat and co-workers (2) also found increased Cu and ceruloplasmin but lowered Zn in adult 
patients with active pulmonary tuberculosis. Correlation between serum Cu and cerulo-
plasmin was found. These results indicated that Cu, Zn and Cu/Zn were indirect pointers 
but not specifi c markers of TBC. Low concentrations of vitamin A and zinc are common in 
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sera of TBC patients. However, Visser et al. (3) detected no eﬀ ect of supplementation with 
vitamin A and zinc aft er an 8-week treatment. Ghulam et al. (4) measured also the signifi -
cant drop of zinc in serum with advanced age and disease, but the values improved aft er 
anti-TBC therapy. Zinc was pointed out as an important tool in diagnostics and monitoring 
of the response to TBC treatment.
While Nenni and co-workers (7) found that supplementation with zinc, vitamin A and 
fi sh oil may be associated with a signifi cant increase in leptin level and signifi cant de-
crease in tumor necrosis factor alpha (TNF-alpha) in children under anti-TBC therapy, 
Herlina et al. (8) investigated the association of serum CRP and leptin in TBC patients and 
found elevated serum CRP and decreased serum leptin associated with an increase in 
wasting in pediatric TBC. Dodig et al. (9) investigated children with latent tuberculosis 
infection (LTBI) to see the eﬀ ects of isoniazid prophylaxis on serum concentrations of 
high-sensitivity CRP (hsCRP) and complement components C3 and C4. hsCRP was low-
ered aft er prophylaxis, showing its usefulness in the follow-up of LTBI patients to evaluate 
the level of disease power and the response to isoniazid treatment.
Continuing our research devoted to the analysis of metal ions in children’s sera (10, 
11), we are applying here new analytical methods for copper and zinc (12). Correlations 
between lung tuberculosis status of children of diﬀ erent age and therapeutic groups with 
the status of copper and zinc and common biochemical parameters are presented.
EXPERIMENTAL
Patients and serum samples
All sera samples were obtained from the Srebrnjak Children’s Hospital, Zagreb, Croa-
tia, in 2006 and 2007, and were stored at –18 °C. All experiments were approved by the 
Ethical Committ ees of the Srebrnjak Children’s Hospital, Zagreb, Croatia, and Faculty of 
Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
The newly established methods were applied to the analyses of remnant children’s’ 
sera (age: 1.5 months to 18 years, N = 96, 48 male, 48 female). Upon admitt ance to the hos-
pital, they were triaged into four groups: TBC group (children with lung tuberculosis, N = 
26, age: 1.5 months to 18 years, administered isoniazid, rifampin, pyrazinamide, and eth-
ambutol); LTBI group (children with latent tuberculosis infection, N = 17, age: 2 to 14 years, 
isoniazid prophylaxis for 6 months at home); contact group (clinically healthy children 
who were in contact with a TBC patient, N = 30, age: 1 to 18 years, CC), controls (N = 23, age 
5 to 18 years, C).
Blood was taken at 8–12 a.m. TBC and LTBI patients’ blood was taken at admitt ance/
starting therapy with isoniazid, rifampin, pyrazinamide and ethambutol or starting pro-
phylaxis with isoniazid, respectively, and for TBC patients, 2–3 times aft er that during a 
3-month follow-up. Time that elapsed between the admitt ance (group TBC.1) and group 
TBC.2 was 7 ± 4 weeks (interval 1.5–14 weeks); in addition, 2–4 weeks elapsed before suc-
cessive measuring of each group, TBC.3 or TBC.4. For LTBI patients, the elapsed time be-
tween the admitt ance (group LTBI.1) and group aft er prophylaxis (group LTBI.2) was 9 to 
11 weeks.
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Metal ions
Newly established analytical methods were applied for analyses of Cu and Zn in 
children’s sera at diﬀ erent dilution levels (12). Cu and Zn were simultaneously determined 
from 5-fold diluted samples (method A). For analysis of Zn alone, an additional analytical 
method involving 10-fold diluted serum samples was suggested (method B). All the ex-
perimental details pertaining to analyses of metal ions are described in detail in ref. 12.
Biochemical assays
Biochemical parameters, immunoglobulins IgG, IgA and IgM, CRP, C3 and C4 were 
determined by the immunoturbidimetric method on latex particles on a Beckman Coulter 
AU 400 biochemistry analyzer (Beckman Coulter, Germany), using reagents from the same 
manufacturer. Erythrocyte sedimentation rate (SE) was assayed using a Vesmatic 20 ana-
lyzer (Diesse Diagnostica Senese S. p. A, Italy). Leukocyte (Lkc) and platelet (Plt) counts 
were determined with a Sysmex XT-1800i analyzer (Sysmex Corporation, Japan). These 
parameters were used to indicate infl ammation in C and CC groups of children. The val-
ues were within reference intervals for both age groups (0–5 and 6–18 years).
Data analysis
For statistical analyses of the patient data 2-tailed statistical tests at a signifi cance level 
of 0.05 were applied. These were non-parametric tests (Mann-Whitney U, Kruskal-Wallis 
and Wilcoxon signed-rank); for normally distributed data Student’s t-test and F-test were 
applied.
RESULTS AND DISCUSSION
Diagnostic outcome and implications in pediatric patients: metal ions and biochemical 
parameters
Four types of pediatric patients were checked for metal ion status and biochemical 
parameters: controls, contacts, LTBI and TBC. LTBI and TBC patients were followed dur-
ing/aft er therapy/prophylaxis as well (LTBI.1&LTBI.2, TBC.1 to TBC.4), resulting in a total 
of 8 experimental groups. Results are presented in Tables I and II and Figs. 1a–d.
Cu and Zn assayed simultaneously by method A. – Results are displayed in Table I and 
Figs. 1a–d. No signifi cant diﬀ erence was found between age groups (0–5 versus 6–18 years) 
for Cu, Zn or their ratio in any of the investigated groups (data not shown). Moreover, no 
signifi cant diﬀ erences were found between controls and contacts and between controls 
and LTBI groups for any of the analytes. Also, signifi cant diﬀ erences were not observed 
between LTBI.1 and LTBI.2 groups as well as between TBC groups, in any combination.
However, metal ions and the respective Cu/Zn ratio diﬀ ered signifi cantly between the 
TBC group at admitt ance (TBC.1) and controls, contacts, LTBI.1 and LTBI.2 (see Figs. 1a–c 
and Table I) for all patients and for the respective age groups, except for zinc.
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Taking all the age groups into account, serum Cu increased from 1.159 ± 0.239 μg mL–1 
in the controls (N = 11) to 1.573 ± 0.429 μg mL–1 in TBC children (N = 12) but returned to 
1.187 ± 0.075 μg mL–1 (N = 4) aft er 3-month treatment. At the same time, Zn decreased from 
1.028 ± 0.264 μg mL–1 in controls (N = 11) to 0.915 ± 0.186 μg mL–1 in TBC patients (N = 12) 
and increased again in the last measurement to 1.114 ± 0.138 μg mL–1 (N = 4). Since serum 
Cu concentration signifi cantly increased (p = 1.278 × 10–2) and that of Zn simultaneously 
decreased in patients with TBC, Cu/Zn ratio increased signifi cantly as well (p = 7.36 × 10–3) 
in TBC patients, but returned to normal values in LTBI and contact persons, and in TBC 
persons within 3 months of therapy/prophylaxis (Fig. 1c). Interesting to note, the fi rst 
strong increase of Cu/Zn ratio from 1.149 ± 0.305 (N = 11) in controls to 1.766 ± 0.525 (N = 12) 
in TBC.1 group came back to 1.081 ± 0.185 (N = 4) aft er commencing the therapy. Analogous 
trends were observed for all age groups.
The scatt er of data within each group for both metal ions in all patient groups (Table 
I) ranged from 10–27 % for Cu and 11–39 % for Zn, and 17–33 % for the ratio. This seems to 
be a result of both method’s intermediate imprecision (about 13 % for both analytes, see 
ref. 12) but dominantly of high between-patient variability. Such a variability amounting 
10–40 % for both metals made the recognition of signifi cant diﬀ erences diﬃ  cult. In line 
with this, no signifi cant diﬀ erence for any metal ion or its ratio, before and during/aft er 
therapy/prophylaxis, was found.
Zn by method B. – Fig. 1d illustrates zinc levels in patients’ sera aft er 10-fold dilution; 
no signifi cant diﬀ erences were observed between any of the groups. No diﬀ erences were 
observed between the age groups either (Table I). One of the possible reasons might be the 
high variability for Zn at 10× dilution level, which ranged from 14 to 53 % within patient 
groups.
Zn values obtained from paired data sets of TBC children (N = 12), namely before 
commencing and during/aft er the therapy (within 3 months), were 0.871 ± 0.373 and 1.016 
± 0.345 μg mL–1, showing a slight still not signifi cant return of Zn level. An opposite trend 
was observed aft er prophylaxis in LTBI groups (0.999 ± 0.686 at admitt ance, followed by 
0.842 ± 0.192 μg mL–1 aft er prophylaxis, N = 6).
Results for Zn when taken all together, show an average return of the value for ca 10 
% aft er commencing the therapy.
Concentrations of both metal ions and their ratio in sera of C and CC groups of chil-
dren comply with the physiological values for general child population (13, 14).
Biochemical parameters. – Measured biochemical parameters are presented in Table II. 
The values for IgG, IgA, IgM, SE, Lkc, and Plt found in samples of C and CC children agree 
well with physiological values (15).
Signifi cant diﬀ erences for IgG and IgA were found between age groups in contacts, 
LTBI.1 and TBC.1 groups (see Table II).
Correlations found between biochemical parameters and metal ions are given in Table 
II. In the TBC.1 group, R ≥ 0.7 was found between Cu and IgA, CRP, C3, C4 and SE, and 
similarly in the LTBI.1 group between Cu and IgM, C3, C4 and SE. CRP, C3 and C4 were 
found to be signifi cantly higher in TBC.1 and LTBI.1 than in controls and/or contacts. These 
results reveal that Cu is involved in both, severe lung infl ammations in patients with TBC 
and in latent infl ammations in patients with LTBI. In TBC patients, severe infl ammation is 
mediated by IgA, CRP, C3, and C4, while in LTBI patients, latent infl ammation is mediated 
by IgM, C3 and C4. Involvement of a complement system was confi rmed in both processes.
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In TBC.1, leukocytes and platelets were also signifi cantly higher than in C and CC. All 
these values levelled oﬀ  during therapy.
No signifi cant diﬀ erences, except for CRP, were observed between biochemical pa-
rameters during/aft er therapy/prophylaxis for up to 3 months. CRP diﬀ ered signifi cantly 
between TBC.1 and TBC.2 groups paired data (Wilcoxon signed-rank test, 11 pairs of data, 
p = 3.662x10–2).
Prognostic/diagnostic applicability of metal ions and biochemical parameters
The data given in Table II connects Cu with CRP, C3, C4 and SE in a set of values, 
which might represent a general indicator of lung tuberculosis status in children. This 
partly agrees with the fi ndings of Moraes et al. (1) and Cernat and co-workers (2). Our fi nd-
ings also demonstrate the usefulness of Cu/Zn ratio, similarly to Cernat et al. (2) who indi-
cated that Cu, Zn and Cu/Zn might be considered indirect pointers but not specifi c mark-
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ers of TBC. Contrary to Ghulam et al. (4), who pointed out Zn as a an important tool in 
diagnostics and monitoring of the response to TBC treatment, our fi ndings do not support 
the idea of the usefulness of zinc level as a good marker in TBC diagnostics/prognostics in 
children. Dodig et al. (9) showed that high-sensitivity CRP, C3 and C4 signifi cantly in-
creased in LTBI and TBC children, the former showing pre-therapy – post-therapy chang-
es, thus being applicable in TBC follow-up. Our fi ndings partly coincide with that of Dodig 
et al. (9): CRP, C3 and C4 returned to lower values aft er therapy/prophylaxis. The main 
limitation of the present study is the lack of an interferon gamma release assay to diagnose 
LTBI (16).
CONCLUSIONS
New analytical methods for Cu and Zn were found fully applicable to simultaneous 
determination of Cu and Zn and Zn alone in sera of healthy children and those with tu-
berculosis infection or suspected TBC. Cu/Zn ratio, along with the set of data including 
Cu, CRP, C3, C4 and SE, have proven useful as reliable prognostic/diagnostic tools when 
solving pediatric tuberculosis problems. More detailed investigations (including determi-
nation of LTBI by an interferon gamma release assay) are needed to clearly defi ne the 
biomarkers that will unequivocally evaluate the level of disease and the response to the 
treatment.
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